3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
2015;314(7):687 Large weight loss trial with liraglutide that demonstrates BP (clinic BP) lowering with liraglutide administration
If you're taking medication for thyroid dysfunction, blood pressure, depression, anticoagulation, or any chronic condition, check supplement interactions with a pharmacist before starting
When youre feeling run down or have the flu, you might turn to a one-time IV therapy
Conversely, the Tri-weekly regimen focuses on convenience and potentially reduces adverse effects but may require a higher dose for effectiveness
But that doesnt necessarily need to be the case, says Wood